Growing challenges for HIV programmes in Asia: clinic population trends, 2003–2013

References

• Antiretroviral Therapy Cohort, C. (2008). Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. The Lancet, 372(9635), 293–299. doi: 10.1016/S0140-6736(08)61113-7
   PubMed Web of Science ®Google Scholar
• Arnedo, M., Alonso, E., Eisenberg, N., Ibanez, L., Ferreyra, C., Jaen, A., … Busia, O. R. S. G. (2012). Monitoring HIV viral load in resource limited settings: Still a matter of debate? PLoS One, 7(12), e47391. doi: 10.1371/journal.pone.0047391
   PubMed Web of Science ®Google Scholar
• Ball, S. C. (2014). The aging HIV population. Clinical Practice, 11(2), 221–231. doi:10.2217/CPR.13.9
   Google Scholar
• Benator, D. A., Elmi, A., Rodriguez, M. D., Gale, H. B., Kan, V. L., Hoffman, H. J., … Squires, L. (2015). True durability: HIV virologic suppression in an urban clinic and implications for timing of intensive adherence efforts and viral load monitoring. AIDS and Behavior, 19(4), 594–600. doi: 10.1007/s10461-014-0917-6
   PubMed Web of Science ®Google Scholar
• Bonner, K., Mezochow, A., Roberts, T., Ford, N., & Cohn, J. (2013). Viral load monitoring as a tool to reinforce adherence: A systematic review. Journal of Acquired Immune Deficiency Syndromes, 64(1), 74–78. doi: 10.1097/QAI.0b013e31829f05ac
   PubMed Web of Science ®Google Scholar
• Boyer, S., March, L., Kouanfack, C., Laborde-Balen, G., Marino, P., Aghokeng, A. F., … Stratall, A. E. S. G. (2013). Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (stratall ANRS 12110/ESTHER): a cost-effectiveness analysis. The Lancet Infectious Diseases, 13(7), 577–586. doi: 10.1016/S1473-3099(13)70073-2
   PubMed Web of Science ®Google Scholar
• Brown, T. T., & Qaqish, R. B. (2006). Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review. AIDS (London, England), 20(17), 2165–2174. doi: 10.1097/QAD.0b013e32801022eb
   PubMed Web of Science ®Google Scholar
• Calmy, A., Ford, N., Hirschel, B., Reynolds, S. J., Lynen, L., Goemaere, E., … Rodriguez, W. (2007). Hiv viral load monitoring in resource-limited regions: Optional or necessary? Clinical Infectious Diseases, 44(1), 128–134. doi: 10.1086/510073
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). (2015). HIV Surveillance Report, 2014.
   Google Scholar
• De La Mata, N. L., Kumarasamy, N., Khol, V., Ng, O. T., Van Kinh, N., Merati, T. P., … Law, M. (2016). Improved survival in HIV treatment programmes in Asia. Antiviral Therapy. doi: 10.3851/IMP3041
   PubMed Web of Science ®Google Scholar
• Duda, S. N., Farr, A. M., Lindegren, M. L., Blevins, M., Wester, C. W., Wools-Kaloustian, K., … International Epidemiologic Databases to Evaluate, A. C. (2014). Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-pacific, sub-saharan Africa and the americas: Results of a site assessment conducted by the international epidemiologic databases to evaluate AIDS (IeDEA) collaboration. Journal of the International AIDS Society, 17, 19045. doi: 10.7448/IAS.17.1.19045
   PubMed Web of Science ®Google Scholar
• Edelman, E. J., Gordon, K. S., Glover, J., McNicholl, I. R., Fiellin, D. A., & Justice, A. C. (2013). The next therapeutic challenge in HIV: Polypharmacy. Drugs & Aging, 30(8), 613–628. doi: 10.1007/s40266-013-0093-9
   PubMed Web of Science ®Google Scholar
• Effros, R. B., Fletcher, C. V., Gebo, K., Halter, J. B., Hazzard, W. R., Horne, F. M., … High, K. P. (2008). Aging and infectious diseases: Workshop on HIV infection and aging: What is known and future research directions. Clinical Infectious Diseases, 47(4), 542–553. doi: 10.1086/590150
   PubMed Web of Science ®Google Scholar
• Estill, J., Ford, N., Salazar-Vizcaya, L., Haas, A. D., Blaser, N., Habiyambere, V., & Keiser, O. (2016). The need for second-line antiretroviral therapy in adults in sub-saharan Africa up to 2030: A mathematical modelling study. The Lancet HIV, 3(3), e132–e139. doi: 10.1016/S2352-3018(16)00016-3
   PubMed Web of Science ®Google Scholar
• Figueroa, M. I., Sued, O., & Cahn, P. (2014). What to do next? Second-line antiretroviral therapy. Current Treatment Options in Infectious Diseases, 6(2), 159–170. doi: 10.1007/s40506-014-0013-5
   Google Scholar
• Gleason, L. J., Luque, A. E., & Shah, K. (2013). Polypharmacy in the HIV-infected older adult population. Clinical interventions in aging, 8, 749–763. doi: 10.2147/CIA.S37738
   PubMed Web of Science ®Google Scholar
• Greene, M., Covinsky, K. E., Valcour, V., Miao, Y., Madamba, J., Lampiris, H., … Deeks, S. G. (2015). Geriatric syndromes in older HIV-infected adults. Journal of Acquired Immune Deficiency Syndromes, 69(2), 161–167. doi: 10.1097/QAI.0000000000000556
   PubMed Web of Science ®Google Scholar
• Group, A.-L. O. I. S., Keiser, O., Tweya, H., Boulle, A., Braitstein, P., Schecter, M., … Egger, M. (2009). Switching to second-line antiretroviral therapy in resource-limited settings: Comparison of programmes with and without viral load monitoring. AIDS (London, England), 23(14), 1867–1874. doi: 10.1097/QAD.0b013e32832e05b2
   PubMed Web of Science ®Google Scholar
• High, K. P., Brennan-Ing, M., Clifford, D. B., Cohen, M. H., Currier, J., Deeks, S. G., … OAR Working Group on HIV and Aging. (2012). Hiv and aging: State of knowledge and areas of critical need for research. A report to the NIH office of AIDS research by the HIV and aging working group. Journal of Acquired Immune Deficiency Syndromes, 60(Suppl 1), S1–S18. doi: 10.1097/QAI.0b013e31825a3668
   PubMedGoogle Scholar
• Hirsch, M. S., Gunthard, H. F., Schapiro, J. M., Brun-Vezinet, F., Clotet, B., Hammer, S. M., … Richman, D. D. (2008). Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an international AIDS society-USA panel. Clinical Infectious Diseases, 47(2), 266–285. doi: 10.1086/589297
   PubMed Web of Science ®Google Scholar
• John, M. (2016). The clinical implications of HIV infection and aging. Oral Diseases, 22(Suppl 1), 79–86. doi: 10.1111/odi.12473
   PubMed Web of Science ®Google Scholar
• Kanapathipillai, R., McGuire, M., Mogha, R., Szumilin, E., Heinzelmann, A., & Pujades-Rodriguez, M. (2011). Benefit of viral load testing for confirmation of immunological failure in HIV patients treated in rural Malawi. Tropical Medicine & International Health, 16(12), 1495–1500. doi: 10.1111/j.1365-3156.2011.02874.x
   PubMed Web of Science ®Google Scholar
• Keiser, O., Chi, B. H., Gsponer, T., Boulle, A., Orrell, C., Phiri, S., … Collaboration, I. S. A. (2011). Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa. AIDS (London, England), 25(14), 1761–1769. doi: 10.1097/QAD.0b013e328349822f
   PubMed Web of Science ®Google Scholar
• Kumarasamy, N., & Krishnan, S. (2013). Beyond first-line HIV treatment regimens: The current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings. Current Opinion in HIV and AIDS, 8(6), 586–590. doi: 10.1097/COH.0000000000000004
   PubMed Web of Science ®Google Scholar
• Long, L., Fox, M., Sanne, I., & Rosen, S. (2010). The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. AIDS (London, England), 24(6), 915–919. doi: 10.1097/QAD.0b013e3283360976
   PubMed Web of Science ®Google Scholar
• Loo, V., Saidel, T., Reddy, A., Htin, K. C., Shwe, Y. Y., & Verbruggen, B. (2012). Hiv surveillance systems in the Asia pacific region. Western Pacific Surveillance and Response, 3(3), 9–14. doi:10.5365/WPSAR.2012.3.2.007
   Google Scholar
• Miller, C. J., Baker, J. V., Bormann, A. M., Erlandson, K. M., Huppler Hullsiek, K., Justice, A. C., … Group, E. S. (2014). Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy. PLoS One, 9(4), e95061. doi: 10.1371/journal.pone.0095061
   PubMed Web of Science ®Google Scholar
• Nettles, R. E., Kieffer, T. L., Kwon, P., Monie, D., Han, Y., Parsons, T., … Siliciano, R. F. (2005). Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART. JAMA, 293(7), 817–829. doi: 10.1001/jama.293.7.817
   PubMed Web of Science ®Google Scholar
• Oni, T., Youngblood, E., Boulle, A., McGrath, N., Wilkinson, R. J., & Levitt, N. S. (2015). Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa- a cross sectional study. BMC Infectious Diseases, 15, 20. doi: 10.1186/s12879-015-0750-1
   PubMed Web of Science ®Google Scholar
• Pujades-Rodriguez, M., Balkan, S., Arnould, L., Brinkhof, M. A., Calmy, A., & MSF, A. W. G. O. (2010). Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries. JAMA, 304(3), 303–312. doi: 10.1001/jama.2010.980
   PubMed Web of Science ®Google Scholar
• Renaud-Thery, F., Nguimfack, B. D., Vitoria, M., Lee, E., Graaff, P., Samb, B., & Perriens, J. (2007). Use of antiretroviral therapy in resource-limited countries in 2006: Distribution and uptake of first- and second-line regimens. AIDS (London, England), 21(Suppl 4), S89–S95. doi: 10.1097/01.aids.0000279711.54922.f0
   PubMed Web of Science ®Google Scholar
• Rodriguez-Penney, A. T., Iudicello, J. E., Riggs, P. K., Doyle, K., Ellis, R. J., Letendre, S. L., … Group, H. I. V. N. R. P. H. (2013). Co-morbidities in persons infected with HIV: Increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care and STDs, 27(1), 5–16. doi: 10.1089/apc.2012.0329
   PubMed Web of Science ®Google Scholar
• Sigaloff, K. C., Hamers, R. L., Wallis, C. L., Kityo, C., Siwale, M., Ive, P., … PharmAccess African Studies to Evaluate, R. (2011). Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa. Journal of Acquired Immune Deficiency Syndromes, 58(1), 23–31. doi: 10.1097/QAI.0b013e318227fc34
   PubMed Web of Science ®Google Scholar
• Teeraananchai, S., Kerr, S. J., Amin, J., Ruxrungtham, K., & Law, M. G. (2016). Life expectancy of HIV-positive people after starting combination antiretroviral therapy: A meta-analysis. HIV Medicine. doi: 10.1111/hiv.12421
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2016). Aids by the numbers. Geneva Retrieved from http://www.unaids.org/sites/default/files/media_asset/AIDS-by-the-numbers-2016_en.pdf
   Google Scholar
• World Health Organisation. (2007). Prioritizing second-line antiretroviral drugs for Adults and adolescents: A public health approach. Author.
   Google Scholar
• World Health Organisation. (2013). Consolidated guidelines on the use of Antiretroviral Drugs for treating and preventing HIV infection: Recommendations for a Public Health approach. Author.
   Google Scholar